Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,537 | 729 | 82.3% |
| Travel and Lodging | $2,226 | 6 | 17.4% |
| Education | $25.52 | 2 | 0.2% |
| Consulting Fee | $11.43 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,733 | 178 | $0 (2024) |
| UCB Biosciences Inc. | $2,051 | 9 | $0 (2019) |
| Janssen Biotech, Inc. | $1,552 | 111 | $0 (2024) |
| ABBVIE INC. | $1,335 | 77 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,045 | 68 | $0 (2024) |
| PFIZER INC. | $991.54 | 123 | $0 (2024) |
| UCB, Inc. | $568.11 | 29 | $0 (2024) |
| Celgene Corporation | $259.98 | 13 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $249.08 | 15 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $243.34 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,064 | 110 | Amgen Inc. ($474.68) |
| 2023 | $1,883 | 101 | Amgen Inc. ($496.80) |
| 2022 | $664.84 | 42 | Novartis Pharmaceuticals Corporation ($183.56) |
| 2021 | $233.09 | 15 | Novartis Pharmaceuticals Corporation ($44.89) |
| 2020 | $520.60 | 36 | Amgen Inc. ($199.05) |
| 2019 | $3,684 | 127 | UCB Biosciences Inc. ($2,051) |
| 2018 | $2,159 | 164 | Janssen Biotech, Inc. ($843.90) |
| 2017 | $1,591 | 143 | Amgen Inc. ($448.04) |
All Payment Transactions
738 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $21.43 | General |
| Category: Immunology | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Immunology | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: INFLIXIMAB | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Inflammation | ||||||
| 11/22/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $21.57 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $38.28 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Inflammation | ||||||
| 09/30/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,001 | 16,854 | $1.6M | $521,645 |
| 2022 | 32 | 1,477 | 56,299 | $2.7M | $920,120 |
| 2021 | 35 | 1,676 | 28,916 | $2.6M | $1.1M |
| 2020 | 34 | 1,555 | 26,032 | $2.4M | $1.0M |
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 13 | 6,451 | $387,000 | $218,077 | 56.4% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 24 | 5,867 | $774,444 | $153,219 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 366 | 569 | $118,352 | $47,804 | 40.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 41 | 2,520 | $85,680 | $44,871 | 52.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 90 | 302 | $42,225 | $13,707 | 32.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 34 | 138 | $38,226 | $12,814 | 33.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 49 | 49 | $21,560 | $7,076 | 32.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 29 | 119 | $17,255 | $5,273 | 30.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 31 | $8,649 | $3,822 | 44.2% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 34 | 179 | $17,900 | $3,625 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $9,630 | $3,139 | 32.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 47 | 47 | $9,400 | $1,630 | 17.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 29 | $4,060 | $1,549 | 38.2% |
| 77071 | Application of stress by physician for joint imaging | Office | 2023 | 39 | 39 | $3,900 | $1,493 | 38.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 46 | 126 | $9,450 | $1,331 | 14.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 34 | 35 | $3,500 | $711.82 | 20.3% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 13 | 21 | $1,575 | $503.85 | 32.0% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 16 | 17 | $2,550 | $459.48 | 18.0% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 11 | 12 | $1,500 | $402.40 | 26.8% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 33 | 273 | $6,825 | $138.56 | 2.0% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 18 | 9,576 | $574,500 | $331,663 | 57.7% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 25 | 7,791 | $1.0M | $217,157 | 21.1% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 11 | 29,600 | $444,000 | $125,728 | 28.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 68 | 6,240 | $212,160 | $106,977 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 373 | 563 | $117,104 | $47,062 | 40.2% |
About Dr. Alexander Brown, MD
Dr. Alexander Brown, MD is a Internal Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043250343.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexander Brown, MD has received a total of $12,799 in payments from pharmaceutical and medical device companies, with $2,064 received in 2024. These payments were reported across 738 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($10,537).
As a Medicare-enrolled provider, Brown has provided services to 5,709 Medicare beneficiaries, totaling 128,101 services with total Medicare billing of $3.5M. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Lexington, KY
- Active Since 06/07/2006
- Last Updated 01/20/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1043250343
Products in Payments
- Enbrel (Biological) $2,268
- SIMPONI ARIA (Biological) $878.00
- XELJANZ (Drug) $813.53
- Humira (Biological) $568.04
- Cimzia (Drug) $546.04
- COSENTYX (Drug) $526.89
- COSENTYX (Biological) $496.27
- TREMFYA (Drug) $332.04
- RINVOQ (Biological) $322.73
- STELARA (Biological) $277.42
- SKYRIZI (Biological) $256.04
- BENLYSTA (Biological) $230.14
- ORENCIA (Biological) $197.36
- KEVZARA (Biological) $165.13
- ACTHAR (Biological) $164.61
- Prolia (Biological) $144.78
- TAVNEOS (Drug) $134.78
- SAPHNELO (Biological) $131.28
- LYRICA (Drug) $128.45
- TALTZ (Drug) $119.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lexington
Dr. Firas Badin, M.d, M.D
Internal Medicine — Payments: $1.9M
Dennis Doherty, Md, MD
Internal Medicine — Payments: $686,622
Dr. Robert Sawyer, M.d, M.D
Internal Medicine — Payments: $232,104
David Mannino, Md, MD
Internal Medicine — Payments: $140,029
Dr. Anastasia Jandes, Md, MD
Internal Medicine — Payments: $90,742
Gloria Vigliani, M.d, M.D
Internal Medicine — Payments: $89,452